Distinct CD8⁺ T Cell Dynamics Associate with Response to Neoadjuvant Cancer Immunotherapies

To address whether successful immune checkpoint inhibitor regimens acted through similar or distinct pathways, investigators robustly and longitudinally characterized transcriptional and proteomic dynamics of CD8+ tumor-infiltrating lymphocytes in a clonal manner.